Royalty Pharma

NASDAQ: RPRX · Real-Time Price · USD
36.34
-0.16 (-0.44%)
At close: Aug 15, 2025, 3:59 PM
36.08
-0.72%
After-hours: Aug 15, 2025, 07:21 PM EDT

Royalty Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
929.03M 477.01M 1.71B 1.54B
Short-Term Investments
58.2M 18.3M 717.04M 1.26B
Long-Term Investments
1.26B 1.01B 14.23B 14.63B
Other Long-Term Assets
33.53M 14.09B 15.13M 4.14M
Receivables
26.96M 775.09M 727.92M 682.66M
Inventory
n/a n/a n/a n/a
Other Current Assets
814.91M 3.8M 90.52M 6.63M
Total Current Assets
1.8B 1.27B 2.55B 2.88B
Property-Plant & Equipment
n/a n/a n/a n/a
Goodwill & Intangibles
n/a 1.78M 14.5M 5.67M
Total Long-Term Assets
16.42B 15.11B 14.26B 14.64B
Total Assets
18.22B 16.38B 16.81B 17.52B
Account Payables
13.37M 15.16M 7.91M 5.62M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
997.77M n/a 997.51M n/a
Other Current Liabilities
166.66M 94.53M 107.2M 107.93M
Total Current Liabilities
1.25B 161.38M 1.17B 171.25M
Long-Term Debt
6.61B 6.14B 6.12B 7.1B
Other Long-Term Liabilities
12.08M 900K 2.5M n/a
Total Long-Term Liabilities
6.63B 6.14B 6.12B 7.1B
Total Liabilities
7.88B 6.3B 7.29B 7.27B
Total Debt
7.61B 6.14B 7.12B 7.1B
Common Stock
45K 45K 107K 106K
Retained Earnings
2.85B 2.52B 1.96B 2.26B
Comprehensive Income
n/a n/a 63K 16.49M
Shareholders Equity
6.95B 6.53B 5.63B 5.78B
Total Investments
245.16M 1.03B 533.94M 15.89B